MedTrace Logo

Mitral Valve Prolapse, Arrhythmias and Mitral Valve Surgery

NCT05562804 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-10-04

No results posted yet for this study

Summary

Mitral valve prolapse (MVP) is associated with malignant ventricular arrhythmias (VA) and sudden cardiac death. A proper electrophysiological and echocardiographic characterization of this population is missing. Moreover, the effects of mitral valve repair on the arrhythmic burden are still matter of debate.

The investigators sought to explore the role of the arrhythmic substrate in the risk stratification of patients with MVP and to assess whether mitral surgery is followed by a significant modification of the baseline arrhythmic pattern.

Conditions

  • Mitral Valve Prolapse
  • Cardiac Arrhythmia

Sponsors & Collaborators

  • Ospedale San Raffaele

    lead OTHER

Principal Investigators

  • Pasquale Vergara, MD, PhD · IRCCS San Raffaele Scientific Institute

  • Michele De Bonis, MD · IRCCS San Raffaele Scientific Institute

  • Guido Ascione, MD · IRCCS San Raffaele Scientific Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-10
Primary Completion
2025-02-10
Completion
2026-02-10

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05562804 on ClinicalTrials.gov